Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

January 1, 2027

Conditions
Acute Heart Failure (AHF)Congestive Heart Failure(CHF)
Interventions
DIAGNOSTIC_TEST

Evaluation of residual congestion at discharge

"Evaluation of residual congestion at discharge will be made using:~* Clinical variables: composite congestion score calculated by summing the individual scores for orthopnoea, jugular venous distension and pedal oedema;~* Imaging variables: non-invasive left ventricular filling pressure, number of LUS B lines and the presence of pleural effusion, Venous Excess UltraSound (VExUS) score;~* Laboratory variables: hemoglobin and hematocrit, NT-proBNP, CA-125, ST2, troponin T, creatinine, AST, ALT, Na, K, urea, bilirubin, C-reactive protein."

Trial Locations (1)

08970

RECRUITING

Complex Hospitalari Universitari Moisès Broggi, Sant Joan Despí

All Listed Sponsors
lead

Consorci Sanitari Integral

OTHER